Vyome Holdings, Inc. (HIND) États Financiers et Données Historiques

Vyome Holdings, Inc. (HIND) — Prix $1.96 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Vyome Holdings, Inc. (HIND): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Vyome Holdings, Inc. a enregistré un chiffre d'affaires de $319714 sur le dernier exercice, avec un CAGR sur 5 ans de -51.0%.

Marges des 12 derniers mois: marge brute 46.5%, marge opérationnelle -32.5%, marge nette -87.2%.

Au prix actuel de $1.96, HIND affiche des résultats négatifs (PER non significatif) et un ROE de -254.62%. La capitalisation boursière s'établit à $14M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$786660$1.3M$606710$15.1M$11.3M$13.6M$11.2M$8.7M$8.0M$319714
Coût des Ventes$431476$936386$164299$5.8M$5.0M$5.3M$4.4M$3.1M$2.9M$112928
Marge Brute$355184$350768$442411$9.3M$6.3M$8.3M$6.8M$5.5M$5.1M$206786
R&D$5.2M$5.8M$5.7M$3.1M$3.5M$2.4M$2.5M$2.3M$1.8M$588258
Frais Généraux$18.0M$26.0M$19.3M$22.1M$15.2M$33.2M$31.3M$17.9M$9.9M$2.4M
Charges Opérationnelles$23.2M$31.8M$25.0M$33.8M$18.7M$66.2M$33.9M$20.2M$12.8M$3.0M
Résultat Opérationnel-$22.8M-$31.4M-$38.5M-$24.5M-$12.5M-$57.9M-$27.1M-$14.6M-$7.7M-$2.7M
EBITDA-$19.5M-$34.4M-$37.0M-$72.9M-$18.1M-$60.6M-$44.3M-$11.2M-$6.6M-$10.3M
Charges d'Intérêt$4.1M$3874$12000$451000$2.0M$832000$11300000$146641
Résultat Avant Impôts-$23.4M-$36.1M-$38.7M-$75.1M-$21.8M-$63.4M-$46.6M-$11.3M-$7.1M-$10.5M
Impôts0-$2.3M-$3.4M-$893000-$181000-$274000-$380000$52000$390000
Résultat Net-$23.4M-$33.8M-$81.2M-$74.2M-$21.6M-$63.1M-$46.2M-$11.4M-$7.1M-$10.3M
BPA$-10548750.00$-4524000.00$-4270786.00$-1094068.00$-503023.26$-419004.00$-157897.00$-2771.94$-345.74$-4.75
BPA Dilué$-10548750.00$-4524000.00$-4270786.00$-1094068.00$-503023.26$-419004.00$-157897.00$-2771.94$-345.74$-4.75
Actions en Circulation (Diluées)0$8$9$22$43$151$293$4107$20622$2.2M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$34627$36551$31591$26955
Marge Brute$15244$19378$14040$11658
Résultat Opérationnel-$868777-$1.4M-$1.1M-$862566
EBITDA-$8.6M-$1.3M-$980071-$713748
Résultat Net-$8.4M-$1.2M-$962910-$685556
BPA$-29.42$-0.21$-0.17$-0.10
BPA Dilué$-29.42$-0.21$-0.17$-0.10

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$3.3M$10.2M$5.5M$2.9M$3.0M$22.8M$4.0M$4.6M$693000$5.0M
Placements à Court Terme$2.5M$23.3M00000000
Créances$143692$488613$917000$4.1M$2.6M$2.8M$2.2M$1.7M$1.0M$98611
Stocks$1.8M$2.8M$984735$1.3M$2.2M$3.0M$3.6M$3.7M$2.5M0
Actifs Courants$5.7M$13.9M$8.7M$10.1M$8.9M$29.9M$9.9M$10.3M$4.6M$5.4M
Immobilisations Corporelles$201000$439000$63548$774000$1.0M$1.7M$869000$310000$154000$75821
Goodwill0$27.2M00000000
Actifs Incorporels0$46.2M$36.9M$28.7M$27.0M$20.8M$26000000$314191
Actifs Totaux$7.0M$88.7M$46.3M$39.7M$39.7M$52.5M$11.3M$10.7M$4.8M$6.5M
Dettes Fournisseurs$1.3M$1.1M$1.6M$4.3M$3.7M$3.5M$1.9M$1.7M$2.2M$647533
Dette à Court Terme0$2.0M$9.9M$1.9M$3.9M0$171000$111000$811000$31258
Passifs Courants$1.3M$1.1M$8.4M$10.4M$11.6M$7.5M$7.5M$3.8M$5.0M$2.7M
Dette à Long Terme$9.9M$8.0M0$2.7M$9.2M00000
Passifs Totaux$4.1M$12.3M$14.6M$15.5M$25.2M$8.2M$7.6M$4.1M$5.0M$2.7M
Réserves-$300.9M-$334.8M-$419.0M-$493.2M-$514.8M-$578.0M-$624.2M-$635.6M-$642.7M-$87.6M
Capitaux Propres$2.9M$76.4M$31.7M$24.1M$14.5M$44.3M$3.7M$6.7M-$253000$2.4M
Dette Totale$143692$488613$6.3M$5.4M$13.3M$279000$171000$262000$967000$31258
Dette Nette-$3.2M-$9.7M$762465$2.5M$10.2M-$22.5M-$3.8M-$4.3M$274000-$5.0M
Fonds de Roulement$4.4M$12.8M$356492-$280000-$2.7M$22.4M$2.4M$6.5M-$397000$2.7M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$5.7M$5.0M$8.8M$7.9M
Actifs Totaux$7.0M$6.5M$10.2M$9.2M
Passifs Totaux$3.1M$2.7M$2.1M$1.9M
Capitaux Propres$2.5M$2.4M$6.7M$6.0M
Dette Totale$38609$31258$22548$17310

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$23.4M-$33.8M-$35.3M-$74.2M-$21.6M-$35.5M-$46.2M-$11.4M-$7.1M-$10.5M
Amortissements$139576$925463$440557$1.7M$1.7M$2.0M$2.2M$154000$22000$11985
Stock-based Compensation$2.3M$4.4M$3.1M$2.3M$1.3M$12.2M$2.1M$766000$184000$6.6M
Variation du BFR$1.9M$1.4M$857216-$1.4M$6000-$2.7M$709000-$4.1M$2.3M$39905
Cash Flow Opérationnel-$20.7M-$24.6M-$27.5M-$14.2M-$8.6M-$15.4M-$21.9M-$17.0M-$4.4M-$3.7M
CapEx-$14000-$137123-$49579-$14000-$390000-$352000-$131000-$4300000
Acquisitions0-$6.2M-$10.3M-$2.0M-$2.0M$2.2M$39000000
Rachat d'Actions0000000000
Dividendes Payés0000000000
Free Cash Flow-$20.7M-$24.7M-$27.5M-$14.2M-$8.9M-$15.7M-$22.0M-$17.0M-$4.4M-$3.7M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel$4.3M-$1.5M-$1.4M-$903712
CapEx-$50$40
Free Cash Flow$4.3M-$1.5M-$1.4M-$903712
Dividendes Payés0000
Stock-based Compensation0$1030190$11051

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)+63.6%-52.9%+2387.0%-25.1%+20.4%-17.4%-22.8%-7.7%-96.0%
Croissance Résultat Net (annuelle)-44.8%-140.0%+8.6%+70.9%-191.9%+26.8%+75.4%+37.4%-43.9%
Croissance BPA (annuelle)+57.1%+5.6%+74.4%+54.0%+16.7%+62.3%+98.2%+87.5%+98.6%
Variation Actions (annuelle)+13.9%+147.2%+98.7%+250.5%+94.2%+1303.2%+402.1%+10380.8%
Croissance FCF (annuelle)-19.6%-11.4%+48.4%+37.1%-75.9%-40.1%+22.8%+74.0%+15.3%
Marge Brute45.2%27.3%72.9%61.7%55.4%61.4%60.5%63.9%63.2%64.7%
Marge Opérationnelle-2897.8%-2440.1%-6353.3%-162.1%-110.2%-425.6%-240.9%-168.7%-96.5%-859.2%
Marge EBITDA-2479.5%-2671.9%-6092.7%-483.4%-160.1%-445.7%-394.4%-128.8%-83.0%-3227.6%
Marge Nette-2969.6%-2627.3%-13375.7%-491.8%-191.4%-464.3%-411.2%-131.2%-89.1%-3209.7%
Marge FCF-2627.5%-1920.9%-4539.2%-94.2%-79.1%-115.6%-196.0%-195.9%-55.3%-1172.6%
Taux d'Imposition Effectif-0.0%6.4%8.9%1.2%0.8%0.4%0.8%-0.5%-0.5%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-3216918.36$-3146500.89$-656828.87$-207906.98$-104356.31$-75279.46$-4140.00$-214.67$-1.73
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)0$8$9$22$43$151$293$4107$20622$2.2M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres-254.62%
Rentabilité du capital investi-57.53%
Rentabilité des actifs-123.23%
Marge brute46.50%
Marge opérationnelle-3250.25%
Marge nette-8716.77%

Santé financière

Dette / Capitaux propres0.00
Ratio de liquidité4.37
Piotroski F-Score3
Altman Z-Score-18.08

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-7.30-12.71-4.22-1.51-2.59-1.14-0.25-0.52-1.29-0.72
P/B0.005.794.981.483.871.623.130.89-36.353.04
P/V0.00343.39259.802.374.975.271.020.691.1523.26
Marge Brute45.2%27.3%72.9%61.7%55.4%61.4%60.5%63.9%63.2%64.7%
Marge Opérationnelle-2897.8%-2440.1%-6353.3%-162.1%-110.2%-425.6%-240.9%-168.7%-96.5%-859.2%
Marge Nette-2969.6%-2627.3%-13375.7%-491.8%-191.4%-464.3%-411.2%-131.2%-89.1%-3209.7%

Entreprises liées: ARMP · CCCC · CDXS · CGEN · IMDX · IPHA · NVCT

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de HIND: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions